Cargando…
Epigenetics in Cancer: A Hematological Perspective
For several decades, we have known that epigenetic regulation is disrupted in cancer. Recently, an increasing body of data suggests epigenetics might be an intersection of current cancer research trends: next generation sequencing, immunology, metabolomics, and cell aging. The new emphasis on epigen...
Autores principales: | Stahl, Maximilian, Kohrman, Nathan, Gore, Steven D., Kim, Tae Kon, Zeidan, Amer M., Prebet, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065123/ https://www.ncbi.nlm.nih.gov/pubmed/27723796 http://dx.doi.org/10.1371/journal.pgen.1006193 |
Ejemplares similares
-
Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities
por: Stahl, Maximilian, et al.
Publicado: (2016) -
Epigenetic therapy combinations in acute myeloid leukemia: what are the options?
por: Bewersdorf, Jan Philipp, et al.
Publicado: (2019) -
Insights into novel emerging epigenetic drugs in myeloid malignancies
por: Chandhok, Namrata S., et al.
Publicado: (2019) -
Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia
por: Uy, Natalie, et al.
Publicado: (2018) -
Epigenetics of hematopoiesis and hematological malignancies
por: Hu, Deqing, et al.
Publicado: (2016)